Detalhe da pesquisa
1.
LP(a): Structure, Genetics, Associated Cardiovascular Risk, and Emerging Therapeutics.
Annu Rev Pharmacol Toxicol;
64: 135-157, 2024 Jan 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37506332
2.
Transitioning to GLP-1 RAs and SGLT2 Inhibitors as the First Choice for Managing Cardiometabolic Risk in Type 2 Diabetes.
Curr Atheroscler Rep;
24(12): 925-937, 2022 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36422789
3.
Vascular control of kidney epithelial transporters.
Am J Physiol Renal Physiol;
320(6): F1080-F1092, 2021 06 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33969697
4.
Coronary artery calcium in 2023: Guidelines for LDL-C goals, non-statin therapies, and aspirin use.
Prog Cardiovasc Dis;
84: 2-6, 2024.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38754533
5.
Online searches for hepatocellular carcinoma drugs mirror prescription trends across specialties and changes in guideline recommendations.
Front Oncol;
14: 1324095, 2024.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38406802
6.
Cardiovascular risk stratification among individuals with obesity: The Coronary Artery Calcium Consortium.
Obesity (Silver Spring);
31(9): 2240-2248, 2023 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37534563
7.
National Trends in Use of Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists by Cardiologists and Other Specialties, 2015 to 2020.
J Am Heart Assoc;
11(9): e023811, 2022 05 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35475341
8.
Online searches for SGLT-2 inhibitors and GLP-1 receptor agonists correlate with prescription rates in the United States: An infodemiological study.
Front Cardiovasc Med;
9: 936651, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35966558